The Chlamydia trachomatis & Neisseria gonorrhoeae PCR Test detects genetic material of Chlamydia trachomatis and Neisseria gonorrhoeae, enabling accurate diagnosis of sexually transmitted infections.
The Chlamydia trachomatis & Neisseria gonorrhoeae Qualitative PCR Test is a highly sensitive molecular test used to detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae.
This test is recommended to:
The Chlamydia trachomatis and Neisseria gonorrhoeae, Qualitative PCR Test is a highly sensitive molecular test that detects the genetic material (DNA) of Chlamydia trachomatis and Neisseria gonorrhoeae, the bacteria responsible for two of the most common sexually transmitted infections (STIs).
Healthcare providers commonly recommend this test for individuals experiencing symptoms such as painful urination, abnormal vaginal or penile discharge, pelvic pain, lower abdominal pain, pain during sexual intercourse, testicular pain, rectal discomfort, or unexplained genital irritation.
Furthermore, this Qualitative PCR Test helps identify active Chlamydia and Gonorrhea infections at an early stage, enabling prompt treatment and reducing the risk of serious complications such as pelvic inflammatory disease (PID), infertility, epididymitis, chronic pelvic pain, ectopic pregnancy, and the spread of infection to sexual partners. Since many infected individuals may have no symptoms, early testing plays a crucial role in preventing long-term health complications and limiting transmission.
The test is often performed using urine samples or swabs collected from the cervix, urethra, vagina, throat, or rectum, depending on the individual's symptoms and exposure history. It is frequently recommended alongside other STI screening tests, including HIV, Syphilis, Hepatitis B, Hepatitis C, Trichomonas, and additional reproductive health investigations for a comprehensive sexual health assessment.
This PCR test detects the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae, helping diagnose active Chlamydia and Gonorrhea infections quickly and accurately, even before symptoms develop.
No. Fasting is not required for this test. Depending on the sample type, your healthcare provider may advise you not to urinate for at least 1–2 hours before providing a urine sample or provide specific instructions for swab collection. Always follow the preparation guidelines given before sample collection.
A positive result indicates that genetic material (DNA) of Chlamydia trachomatis, Neisseria gonorrhoeae, or both has been detected, suggesting an active infection. Your healthcare provider will interpret the results along with your symptoms and medical history, prescribe appropriate antibiotic treatment, and may recommend testing and treatment for your sexual partner(s) to help prevent reinfection.